Value of bilirubin oxidase and its mutants in the diagnosis of hyperbilirubinemia

Abstract

Abstract: Objective To elucidate the significance of the coordination amino acid residues in bilirubin oxidase (BO) and their kinetic characteristics, and evaluate whether BO mutants may serve as better diagnostic agent for hyperbilirubinemia. Methods The BO mutants I402G and C457S were obtained by site-directed mutagenesis and confirmed by amino acid sequence analysis. Ru-incorporated C457S mutant was obtained by direct incubation of ruthenium compounds with the mutant. The electron paramagnetic resonance (EPR) spectra of the recombinant BO and the mutants were investigated, and the enzyme kinetics of the recombinant BO and I402G mutant were measured with bilirubin as the substrate at 25 ℃. Results The BO mutants were expressed and purified successfully. The mutant I402G showed low enzyme activity, and had C457S virtually no enzyme activity. Nevertheless Ru-incorporation conferred higher enzyme activity to C457S mutant. The enzyme kinetic investigations revealed that the kinetic parameter k_cat of the recombinant BO and I402G mutant was 235.8 min^-1 and 6.9 min^-1, respectively, suggesting higher enzyme activity of the recombinant BO. Conclusions The coordinating amino acids have important significance in maintaining the integrity of active centers and enzyme activities of recombinant BO and its mutants. The enzyme activities of the mutants I402G and C457S are much lower than those of recombinant BO, therefore they are not appropriate for diagnostic purpose. Ru-incorporation facilitates the formation of a new intact active center in C457S mutant, which therefore acquires enzyme activity.

CLC Number:

ZHANG Lei¹, ZHANG Xiao², LUO Zhi-Ying³. Value of bilirubin oxidase and its mutants in the diagnosis of hyperbilirubinemia[J]. Journal of Southern Medical University, 2005, 25(11): 1337-1340.

References

[1] Liu YR, Zhu B, Wang XF, et al. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis-implication for the role of oxidative stress in the development of multiple-sclerosis[J]. J Neuroimmunol, 2003, 139(1): 27-35.
[2] Kwak JY, Takeshige K, Cheung BS, et al. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell free-system[J]. Biochim Biophys Acta, 1991, 1076(2): 369-73.
[3] Hsia DYY, Allen FH, Gellis SS, et al. Erythroblastosis fetalis Ⅲ.Studies of serum bilirubin in relation to Kernicterus[J]. N Engl J Med, 1952, 247(2): 668-71.
[4] Hansen TWR, Allen JW, Tommarello S. Oxidation of bilirubin in the brain-further characterization of a potentially protective mechanism[J]. Mol Genet Metab, 1999, 68(1): 404-9.
[5] Ostrow JD., Pascolo L, Tiribeli C. Reassessment of the unbound concentration of unconjugated bilirubin in relation to neurotoxicity in vitro[J]. Pediat Res, 2003, 54(1), 98-104.
[6] McDonagh AF, Lightner DA. Like a shriveled blood orange-bilirubin, jaundice and phototherapy[J]. Pediatrics, 1985, 75(2): 443-5.
[7] Hansen TWR. Mechanisms ofbilirubin toxicity-clinical implication[J]. Clin Perinatol, 2002, 29940: 765.
[8] Hansen TWR, Allen JW. Oxidation of bilirubin by brain mitochondrial membranes-dependence on cell type and postnatal age[J].Biochem Mol Med, 1997, 60(1): 155-60.
[9] Shimizu A, Kwon JH, Sakurai T, et al. Myrothecium verrucaria bilirubin oxidase and its mutants for potential copper ligands[J].Biochem, 1999, 38(6): 3034-42.
[10] Kosaka A, Yamamoto C, Morishita Y, et al. Enzymatic determination of bilirubin fractions in serum[J]. Clin Biochem, 1987, 20(6):451-8.
[11] Andreu Y, Galban J, de Marcos S, et al. Determination of directbilirubin by a fluorimetric-enzymatic method based on bilirubin oxidase[J]. Fresenius J Anal Chem, 2000, 368(5): 516-21.
[12] Dai J, Parry DM, Krahn J. Transcutaneous bilirubinometry: its role in the assessment of neonatal jaundice[J]. Clin Biochem, 1997, 30(1): 1-9.
[13] Bhutani VK, Johnson LH, Gourley G. Measuring bilirubin through the skin[J]. Pediatrics 2003, 111(4): 919.
[14] Ozkan H, Oren H, Duman N, et al. Dermal bilirubin kinetics during phototherapy in term neonates[J]. Acta Paediatr, 2003, 92(5): 577-81.
[15] Ostrow JD, Pascolo L, Shapiro SM, et al. New concepts in bilirubin encephalopathy[J]. Eur J Clin Invest, 2003, 33(6): 988-97.
[16] Sakurai T, Zhan L, Fujita T, et al. Authentic and recombinant bilirubin oxidases are in different resting forms[J]. Biosci Biotechnol Biochem, 2003, 67(5): 1157-9.
[17] Sakurai T, Tanaka K, Kitagawa R, et al. Construction of a new expression system of bilirubin oxidase and its mutants to explore the dioxygen reduction mechanism[J]. J Inorg Biochem, 2003, 96(1): 223.
[18] Shimizu A, Sakurai T. Yamaguchi S, et al. Mutation of bilirubin oxidase by protein engineering for elucidating electron pathway[J]. J Inorg Biochem, 1997, 67(1): 56.